ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 10.80
+0.50 (4.85%)
May 6, 2026, 2:02 PM CET
ViroGates Company Description
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector.
It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma; and suPARnostic Quick Triage, a test for rapid, quantitative measurement of suPAR levels.
ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.
ViroGates A/S
| Country | Denmark |
| Founded | 2000 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Jakob Knudsen |
Contact Details
Address: Banevaenget 13 Birkerød, 3460 Denmark | |
| Phone | 45 21 13 13 36 |
| Website | virogates.com |
Stock Details
| Ticker Symbol | VIRO |
| Exchange | Copenhagen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | DKK |
| ISIN Number | DK0061030574 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Jakob Ole Knudsen | Chief Executive Officer |
| Dr. Jesper Eugen-Olsen | Co-Founder and Chief Scientific Officer |
| Josephine Baum Jorgensen | Chief Financial Officer |
| May Britt Dyvelkov | Vice President of Accounting |
| Dr. Thomas Krarup | Vice President of Global Sales and Marketing |